Copertina

Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Benjamin R. Underwood, Ilianna Lourida, Jessica Gong, Stefano Tamburin, Eugene Yee Hing Tang, Emad Sidhom, Xin You Tai, Matthew J. Betts, Janice M. Ranson, Margarita Zachariou, Olajide E. Olaleye, Saswati Das, Neil P. Oxtoby, Shanquan Chen, David J. Llewellyn
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Anti‐epileptic drug use and subsequent degenerative dementia occurrence
di: Naoki Ikegaya, et al.
Pubblicazione: (2024)

Vascular cognitive impairment and dementia drug‐development pipeline 2025
di: Ying Xu, et al.
Pubblicazione: (2026)

Effects of check‐in interval on active engagement in people with dementia
di: Ebonee Hodder, et al.
Pubblicazione: (2024)

Anticholinergic drugs and dementia risk: Using stem cell–based studies to complement pharmacoepidemiology
di: Tiara A. Schwarze‐Taufiq, et al.
Pubblicazione: (2025)

Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study
di: Takashi Yanagiuchi, et al.
Pubblicazione: (2024)

Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels
di: Alessandro Sciahbasi, et al.
Pubblicazione: (2024)

Navigating challenges in drug‐coated balloon technology: The saga between paclitaxel and sirolimus continues
di: Bernardo Cortese, et al.
Pubblicazione: (2024)

Comparison of thrombogenicity in different types of drug‐eluting stents during transition from DAPT to SAPT
di: Kenji Kawai, et al.
Pubblicazione: (2024)

Safety and efficacy of drug‐eluting stents for patients at high risk of bleedings: A network meta‐analysis
di: Federico Giacobbe, et al.
Pubblicazione: (2024)

Comprehensive clinical outcomes of drug‐coated balloon treatment for coronary artery disease. Insights from a single‐center experience
di: Atsushi Funatsu, et al.
Pubblicazione: (2024)

Sick sinus syndrome and high‐degree atrioventricular block in dementia with Lewy bodies and other dementia subtypes: A study of ≈ 73,000 patients with dementia
di: Isak Heyman, et al.
Pubblicazione: (2025)

The momentum for dementia research in Brazil
di: Mychael V. Lourenco
Pubblicazione: (2026)

Comparative long‐term efficacy and safety of two paclitaxel‐coated balloons with different coating strategies for the treatment of drug‐eluting coronary stent restenosis
di: Tobias Koch, et al.
Pubblicazione: (2024)

Prevalence of metabolic syndrome and its associated factors in first‐treatment drug‐naïve schizophrenia patients: A large‐scale cross‐sectional study
di: Suoya Hu, et al.
Pubblicazione: (2024)

Building digital solutions to support brain health prescribing in primary care: Where to begin?
di: Joyce Siette, et al.
Pubblicazione: (2024)

Choosing the Right Tool: Comparing Risk Stratification Models in Intermediate‐Risk Pulmonary Embolism
di: Robert S. Zhang, et al.
Pubblicazione: (2025)

Alzheimer's disease drug development pipeline: 2026
di: Jeffrey L. Cummings, et al.
Pubblicazione: (2026)

Alzheimer's disease drug development pipeline: 2025
di: Jeffrey L. Cummings, et al.
Pubblicazione: (2025)

Systematic review and meta‐analysis of antipsychotic discontinuation in dementia
di: Sophie Roche, et al.
Pubblicazione: (2025)

Awareness and cognitive rehabilitation in Alzheimer's disease and frontotemporal dementia
di: Eric Salmon, et al.
Pubblicazione: (2024)

Care staff perspectives of clinically meaningful outcomes for dementia residents
di: Alaine E. Reschke‐Hernández, et al.
Pubblicazione: (2025)

A psychometric study of the Flourishing Scale for people living with dementia
di: Chris Clarke, et al.
Pubblicazione: (2025)

Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies
di: Rachel J. Heo, et al.
Pubblicazione: (2025)

Two new positive psychosocial measures for persons living with dementia
di: Sheila L. Molony, et al.
Pubblicazione: (2025)

Alzheimer's disease drug development in an evolving therapeutic landscape
di: Stacie Weninger, et al.
Pubblicazione: (2024)

Profiling the needs of dementia caregivers in a Brazilian cross‐sectional study
di: Alan Cronemberger Andrade, et al.
Pubblicazione: (2025)

Locus coeruleus alterations in dementia with Lewy bodies: A systematic review
di: Anaëlle Bain, et al.
Pubblicazione: (2026)

Perspectives on meaningful dementia treatment and care from those with lived experience
di: Walter Moczygemba, et al.
Pubblicazione: (2025)

The association of dementia risk symptoms and functional activity in adults with Down syndrome
di: Selena E. Washington, et al.
Pubblicazione: (2024)

Supporting dementia caregivers: The role of “lived experience” and public health collaboration
di: Chelsea Kline, et al.
Pubblicazione: (2025)

Resources for estimating dementia prevalence at the state and local levels in the United States
di: Erin E. Bennett, et al.
Pubblicazione: (2026)

Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
di: Luke E. Stoeckel, et al.
Pubblicazione: (2025)

Statin use and dementia risk: A systematic review and updated meta‐analysis
di: Fernando Luiz Westphal Filho, et al.
Pubblicazione: (2025)

A common outcome set for trials in dementia with Lewy bodies (DLB COS)
di: Joseph P. M. Kane, et al.
Pubblicazione: (2025)

Discrepancies between self‐ and proxy‐rated quality of life in people living with dementia
di: Maresa Buchholz, et al.
Pubblicazione: (2024)

Rural–urban disparities of Alzheimer's disease and related dementias: A scoping review
di: Mackenzie Kramer, et al.
Pubblicazione: (2025)

Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia
di: Kenichiro Sato, et al.
Pubblicazione: (2025)

Unforgettable: The power of community in the pursuit of health equity for Alzheimer's disease and other dementia
di: Beverly M. Berry, et al.
Pubblicazione: (2025)

The utility of a composite endpoint for tracking disease progression in Lewy body dementia
di: Elie Matar, et al.
Pubblicazione: (2026)

Modeling amyloid plaque turnover dynamics improves characterization of drug effects
di: Eline van Maanen, et al.
Pubblicazione: (2025)